Got $10,000? Lockheed Martin Could Be a Defense Powerhouse That Outlasts Trump's Term

Lockheed Martin reported Q1 fiscal 2026 revenue of $18.0B versus $18.3B expected, with EPS of $6.44 missing the $6.74 consensus. Revenue was flat year over year, operating margin fell 160 bps to 11.7%, net margin declined 110 bps to 8.3%, and free cash flow turned negative as capex rose 12% to $511M. Management highlighted multiyear Pentagon agreements to accelerate munitions production, and 2026 EPS guidance of $29.35-$30.25 implies up to 37% growth at the midpoint despite near-term margin pressure.

Analysis

The market is keying off the earnings miss, but the more important signal is that Lockheed is entering a capex-heavy conversion phase where reported margins can lag contract economics by several quarters. That creates a classic “good revenue, bad optics” setup: near-term FCF and EPS are pressured just as backlog quality improves, which can leave the stock cheap exactly when the earnings base is about to step up. The operating leverage should show up first in missile-centric programs, where incremental volume typically carries better margin recovery than legacy aircraft production.

The second-order winner is not just LMT, but the broader munitions and components supply chain: propulsion, guidance, energetics, and specialty electronics vendors should see tighter order books as primes accelerate throughput. If production targets truly ramp 3x-4x, the bottleneck shifts from demand to industrial capacity, which can support pricing power and multi-year visibility for small caps feeding the platform. That also means the main execution risk is less end-demand and more labor, supplier qualification, and working-capital drag, all of which can delay margin inflection by 2-4 quarters.

The contrarian miss in the tape is that investors are treating the quarter like a demand problem rather than a timing problem. If the government’s push is durable, the relevant valuation anchor becomes normalized earnings power in 2027-2028, not trailing free cash flow after a one-time investment spike. The stock can still de-rate further if the administration pressures margins faster than volumes ramp, but that would likely be a temporary compression unless procurement priorities change materially.

For the rest of defense, this is mildly negative for peers dependent on discretionary aircraft or slower-cycle programs, and relatively positive for pure munitions exposure. The best hedge is to separate volume beneficiaries from margin-squeezed primes: the former should re-rate on visibility, while the latter may face headline-driven multiple compression before recovering on backlog conversion.

Key Decisions for Investors

• Initiate a staggered long LMT over 4-8 weeks; add on further post-earnings weakness. Risk/reward favors a 12-18 month hold if the market continues to price the stock off depressed near-term FCF rather than 2027 earnings power.
• Pair trade: long LMT / short a slower-cycle defense prime with heavier exposure to aircraft execution and less direct munitions leverage. The thesis is that missile throughput inflects faster than platform programs, creating a relative earnings surprise over the next 2-4 quarters.
• Build a basket long in munitions-enabling suppliers for a 6-12 month horizon. Focus on names exposed to propulsion, energetics, and guidance content; these are the clearest second-order beneficiaries if annual production rates truly triple or quadruple.
• Use put spreads on LMT only if you expect policy rhetoric to force near-term margin compression without offsetting volume. The risk/reward improves for bears only if the ramp stalls for more than one quarter, not on a single earnings miss.
• If long LMT, pair with a short in a defense name with lower backlog conversion visibility to isolate the production-ramp thesis from general defense spending beta.